Privi Speciality Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 03, 2025.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2025, with an unmodified (clean) audit opinion issued by BSR & Co. LLP. On a standalone basis, revenue from operations rose about 19% year-on-year to roughly Rs. 2,038 crore, while net profit surged around 167% to about Rs. 254 crore compared with Rs. 95 crore last year. The Board has recommended a final dividend of Rs. 5 per share (50% on the Rs. 10 face value), aggregating to Rs. 1,953.13 lakhs, subject to shareholder approval. BSR & Co. LLP has been re-appointed as statutory auditors for a second five-year term, and Rathi & Associates has been appointed as secretarial auditor for five years from FY26. The 40th AGM is scheduled for August 1, 2025, with the record date for dividend eligibility set at July 24, 2025.
Strong profit growth, a clean audit report, and a 50% dividend signal robust operational performance and healthy cash returns for shareholders, likely supporting positive investor sentiment. Continuity of the statutory auditor and absence of any qualifications reduce governance concerns for the stock.